Our guest today is Dr. Leo Otterbein, a professor of surgery at Beth Israel Deaconess Medical Center and Harvard Medical School. Leo’s research group focuses on the role of carbon monoxide as a therapeutic agent in medical applications ranging from organ transplant to infection to cancer. Inhaled carbon monoxide is currently in numerous FDA trials based in large part due the research in Leo's lab over the past decade. Leo is also chair of the Beth Israel Deaconess Medical Center (BIDMC) Institutional Animal Care and Use Committee. As the site miner for the BIDMC Center for the Integration of Medicine and Innovative Technology and member of the Boston Biomedical Innovations Center Technology Assessment and Development Group, Leo mentors and provides specialized expertise in entrepreneurial start-up ventures for innovative technologies. Leo trains graduate students, post-doctoral fellows, surgical residents, and junior faculty in basic research, grant proposals and career guidance. 

On the episode, we talk about the myriad possibilities of carbon monoxide (yes, carbon monoxide!) in medicine, ranging from its use in organ transplantation, cancer, wound care, and sickle cell anemia.

Hosted on Acast. See acast.com/privacy for more information.